Beatrice Wiafe-Addai Named Candidate for UICC Board of Directors 2026–2028
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer
Multi-Modal AI May Refine Adjuvant Escalation in High-Risk HR+/HER2− Early Breast Cancer
Proton Therapy vs Photon Therapy: Differences, Benefits, and Side Effects
BGT26 Annual Conference with Dr. Nagla Abdel Karim
Fabrice André and Miguel Bronchud Discuss Key Challenges in Precision Cancer Prevention and Immuno-Oncology
Alexandre Chan: New ASPIRE Initiative Focuses on Life After Cancer in Asia
The Big Questions in Cancer Immunotherapy: Can We Build an Immune System Inside the Tumor?
